ANAPLASTIC MENINGIOMA

This adverse event was reported 29 times

ANAPLASTIC MENINGIOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LUTETIUM LU 177 DOTATATE 4 0.0007
1 PANITUMUMAB 4 0.0002
2 MIFEPRISTONE 1 0.0002
3 EVEROLIMUS TABLETS 3 0.0002
4 HYDROXYUREA 2 0.0001
5 BEVACIZUMAB 11 0.0001
6 EVEROLIMUS 4 0.0001
7 IRINOTECAN HYDROCHLORIDE 1 0.0001
8 OCTREOTIDE ACETATE 2 0.0001
9 LACOSAMIDE 2 0.0001
See all drugs enriched for association with ANAPLASTIC MENINGIOMA